omega-n-methylarginine has been researched along with arl 17477 in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (arl 17477) | Trials (arl 17477) | Recent Studies (post-2010) (arl 17477) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 6 | 0 | 4 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | arl 17477 (IC50) |
---|---|---|---|
Nitric oxide synthase, endothelial | Homo sapiens (human) | 3.5 | |
Nitric oxide synthase, brain | Homo sapiens (human) | 0.035 | |
Nitric oxide synthase, inducible | Homo sapiens (human) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burton, G; Hillmann, M; Hölscher, P; Jaroch, S; McDonald, FM; Rehwinkel, H; Sülzle, D | 1 |
1 other study(ies) available for omega-n-methylarginine and arl 17477
Article | Year |
---|---|
Dihydroquinolines with amine-containing side chains as potent n-NOS inhibitors.
Topics: Amines; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Quinolines; Recombinant Proteins; Reference Values; Structure-Activity Relationship | 2003 |